Post-progression outcomes following BCMA-directed CAR T-cell therapy in myeloma: impact of extramedullary and paramedullary disease.
Saved in:
| Title: | Post-progression outcomes following BCMA-directed CAR T-cell therapy in myeloma: impact of extramedullary and paramedullary disease. |
|---|---|
| Authors: | Abuhelwa Z; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.; Morsani College of Medicine, University of South Florida, Tampa, FL, United States., Amisha F; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.; Morsani College of Medicine, University of South Florida, Tampa, FL, United States., Fan W; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States., De Avila G; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.; Morsani College of Medicine, University of South Florida, Tampa, FL, United States., Hansen DK; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.; Morsani College of Medicine, University of South Florida, Tampa, FL, United States., Grajales-Cruz AF; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.; Morsani College of Medicine, University of South Florida, Tampa, FL, United States., Blue B; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.; Morsani College of Medicine, University of South Florida, Tampa, FL, United States., Castaneda O; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.; Morsani College of Medicine, University of South Florida, Tampa, FL, United States., Liu H; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.; Morsani College of Medicine, University of South Florida, Tampa, FL, United States., Freeman CL; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.; Morsani College of Medicine, University of South Florida, Tampa, FL, United States., Nishihori T; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.; Morsani College of Medicine, University of South Florida, Tampa, FL, United States., Locke FL; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.; Morsani College of Medicine, University of South Florida, Tampa, FL, United States., Shain KH; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.; Morsani College of Medicine, University of South Florida, Tampa, FL, United States., Baz R; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.; Morsani College of Medicine, University of South Florida, Tampa, FL, United States., Alsina M; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.; Morsani College of Medicine, University of South Florida, Tampa, FL, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Oct 27; Vol. 15, pp. 1663814. Date of Electronic Publication: 2025 Oct 27 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2025.1663814 |
